Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 75.40

+5.5%

Nov 11 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mlkr who wrote (3025)	7/13/2010 7:39:28 PM
From: Jibacoa	1 Recommendation Read Replies (1) of 3722

TRBN seems to have found support at the $2.35 level. Today it was just closing yesterday's little UG before trying the resistance at the $3 level<g> bigcharts.marketwatch.com I mentioned that PFE had decided to discontinue development of PF-05212374, one of the two investigational R.A. drugs on which the companies are collaborating. But the other TRBN's drug candidate for R.A., SBI-087 will still continue on its PII as PFE's PF-05230895 and the companies are still evaluating SRI-087 as a possible treatment for S.L.E. TRBN also has some other drugs in its pipeline. Message 26677780 The stock remains speculative, but I still will keep my T.T. at the $5 level.<g> Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next